|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/20 | |
| A61K 9/00 |
| (11) | Number of the document | 2770983 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12780396.3 |
| Date of filing the European patent application | 2012-10-24 | |
| (97) | Date of publication of the European application | 2014-09-03 |
| (45) | Date of publication and mention of the grant of the patent | 2017-04-19 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2012/061701 |
| Date | 2012-10-24 |
| (87) | Number | WO 2013/063125 |
| Date | 2013-05-02 |
| (30) | Number | Date | Country code |
| 201161550653 P | 2011-10-24 | US | |
| 201261680856 P | 2012-08-08 | US |
| (72) |
SCHWARZ, Alexander, US
BOSE, Sagarika, US
QUANDT, Harry, US
KUZMA, Petr, US
CAIZZA, Richard, US
BAI, Stephen, US
KIRBY, Mark, Toddman, US
TZANIS, Evangelos, Loucas, US
|
| (73) |
Braeburn Pharmaceuticals, Inc.,
47 Hulfish Street, Princeton, NJ 08542,
US
|
| (54) | IMPLANTABLE DRUG DELIVERY COMPOSITIONS AND METHODS OF TREATMENT THEREOF |
| IMPLANTABLE DRUG DELIVERY COMPOSITIONS AND METHODS OF TREATMENT THEREOF |